Contract facts
FederalNo full NAICS 811210 intel page yet. Browse NAICS intelligence
INCREMENTAL FUNDING is a federal award for 6973gh Franchise Acquisition Svcs held by The Bionetics Corp. Estimated value $6.5M ($6.5M obligated). Current period of performance ends Dec 31, 2026. Place of performance: YORKTOWN VA.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordThe Bionetics Corp — $83.5M obligated across 37 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 6973GH26F00260?
6973GH26F00260 (Incremental funding) is a 6973gh Franchise Acquisition Svcs award with a potential value of $6.5M, currently held by The Bionetics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 6973GH26F00260?
6973gh Franchise Acquisition Svcs awarded 6973GH26F00260 to The Bionetics Corp (potential $6.5M).
Who is the incumbent on 6973GH26F00260?
The Bionetics Corp is the incumbent with $83.5M across 37 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does The Bionetics Corp’s 6973GH26F00260 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.